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1. Introduction
Macrophages are an important part of the innate immune
system that provides defence to our body from different matter
(pathogens, cellular debris, cancer cells, and so on) and support
tissue repair.[1] Depending on their microenvironment,
macrophages can follow two different path-
ways. This leads to their polarization into
two subpopulations with antagonistic prop-
erties: 1) classically activated macrophages
(M1) that inhibit cell proliferation and
cause tissue damage and 2) alternatively
activated macrophages (M2) that promote
cell proliferation and tissue regeneration.[2]
The balance in this polarization is key in an
effective immune response, but dysregula-
tion can cause or aggravate disease.[3] In
particular, some cancers, such as malig-
nant melanoma, can induce polarization
turning the macrophages against the
healthy tissues. The development of malig-
nant melanoma has been attributed to the
presence of specific macrophage subpopu-
lations, which can be found adjacent to
tumor tissue.[4,5] Such “tumor associated
macrophages” (TAMs) belong to the sub-
type M2 which exhibit anti-inflammatory
activities.[6] TAMs can boost tumorigenesis
by supporting proliferation, invasion and metastasis, stimulate
angiogenesis, and inhibit antitumor immune response.[7–9]
Accordingly, TAMs are an emerging target for diagnostic
purposes[8,10] and prognosis of disease clinical course.[11,12]
Thus, the development of platforms for selective capture that
enable studying the behavior of specific subpopulations of
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Macrophages will play an important role in future diagnostics and immuno-
therapies of cancer. However, this demands to selectively capture and sort
different subpopulations, which remains a challenge due to their innate ability to
bind to a wide range of interfaces indiscriminately. The main obstacle here is the
lack of interfaces combining sufficient antifouling properties with the display of
specific binding sites allowing sorting and quantification. Herein, as a proof of
principle means, it is introduced to pattern interfaces to locally and selective
capture macrophages. The repellent coating is based on antifouling polymer
brushes, which can be functionalized. Arrays of binding sites are constructed by
microchannel cantilever spotting. Those structures are tested for the isolation of
different macrophage subtypes, especially polarized anti-inflammatory macro-
phages of the M2 type which can be found associated to tumors (“tumor
associated macrophages”; TAMs). Using macrophages as a model system, it is
demonstrated that the newly developed surfaces and patterns are efficient for
specifically trapping targeted cells and can be useful for further development of
therapeutic or diagnostic purposes in the future.
RESEARCH ARTICLE
www.advnanobiomedres.com
Adv. NanoBiomed Res. 2020, 2000029 2000029 (1 of 9) © 2020 The Authors. Published by Wiley-VCH GmbH
macrophages are of high interest for diagnostics, treatment, and
follow-up of therapies.[13]
One way to accomplish this task is to introduce surfaces that
can selectively capture the targeted cells at precise locations while
preventing nonspecific binding of other cells or other subpopu-
lations. The specific capture is usually achieved by introducing
receptors or ligands that are complementary to those expressed
in the desired cells but orthogonal to others, while the prevention
of unspecific adhesion demands to generate physical barriers
that repel cells. Nevertheless, surfaces capable of specifically
capturing macrophage subpopulations are still lacking.[14] This
can be attributed to 1) the inherent ability of macrophages to
unspecifically adhere to a large variety of surfaces, posing a much
greater challenge to capture them with specificity and spatial
control than other types of cells and 2) surfaces that can repel
or attract macrophages [e.g., patterned polyethylene glycol
(PEG) hydrogels,[15–17] or polysaccharides[18]] offer no discrimi-
nation of macrophage subtype and often still suffer a satisfying
lack of adhesion contrast between areas that repel and areas that
attract macrophages.[19–24] Thus, also the solution will be twofold,
addressing 1) by efficiently supressing unspecific adhesion and
2) offering highly specific binding capable of addressing macro-
phage subpopulations selectively.
The key to prevent unspecific adhesion (thus addressing chal-
lenge (1)) is on one hand to create a general barrier to cell adhe-
sion and on the other hand to prevent the adsorption of proteins
that promote binding of macrophages to the newly developed
interface. Two types of mechanisms are in place: adsorption
of protein to minimize the interfacial energy between the surface
and water (a very unspecific mechanism) and the specific binding
of proteins from the complement system that signal macro-
phages to adhere. In this work, both mechanisms are termed
fouling. Not only do these adsorbed proteins act as a conditioning
film but also obscure the specific interactions of cells with immo-
bilized receptors.[25–27] To eliminate the fouling from proteins,
different strategies have been developed to minimize or prevent
protein adsorption.[28–30] They are based on reducing the driving
force to fouling, for example, using hydrophilic self-assembled
monolayers (SAMs) or polymers,[31,32] using peptides[33,34] or
even protein–polymer hybrids.[35] Another strategy is the use
of superhydrophobic coatings that have extremely low polariz-
ability thus minimizing the driving force for adsorption.[36,37]
Even commonly used coatings based on end-grafted PEG that
displayed excellent antifouling properties for single protein
solutions such as albumin, failed to prevent fouling from
complex biological media such as undiluted blood plasma.[32]
Furthermore, despite the fact that these coatings cannot be easily
functionalized, they also induce activation of macrophages and
their adsorption.[38,39] To date, only surface modifications based
on polymer brushes, prepared using a grafting-from approach,
are able to prevent fouling from both, single protein solutions
and complex real biological media, such as saliva, undiluted
blood plasma, and blood.[27,40–43] The high grafting density of
the brushes obtained by the grafting-from approach results in
coatings that are impenetrable for macromolecules (autophobic
effect)[44] and acts as entropic barrier for adsorption of protein
and cells. Hydrophilic polymer brushes reduce the interfacial
energy with water and as a result reduce the thermodynamic
drive to adhesion. Antifouling polymer brush coatings have been
already implemented in the development of biosensors able
to detect biomarkers in undiluted biological media in relevant
concentration for clinical diagnostic and food safety.[45–49]
To address challenge (2) and introduce selectivity for subpopu-
lations of macrophages, targeted and site-specific functionaliza-
tion of the antifouling surface needs to be achieved.
Hierarchically structured polymer brushes can combine both—
antifouling properties and capability to be functionalized with
biomacromolecules.[45,50] Previously, we reported “clickable”
polymer brushes that after biofunctionalization were able to
detect analytes in blood plasma without disruption of their
antifouling properties.[51] These brushes consist of two blocks:
an antifouling bottom block and an azide-functional top block.
The azide groups are able to “click” dibenzocyclooctine or bicy-
clononyne without any catalyst and immobilize bioreceptors
attached to it via catalyst-free strain-promoted alkyne–azide cyclo-
addition (SPAAC).[52–54] Simultaneously, the antifouling block
prevents any nonspecific protein adsorption. As a result, this sur-
face modification is a model label-free biosensing platform.
In the present work, we aim at demonstrating the basic prin-
ciple of selective capturing of macrophage subpopulations on
array structures. Such studies would pave the road for future
applications in diagnostic devices, giving access to ordered arrays
of different macrophage subtypes. Maskless lithography can pro-
vide the desired feature density and size that will be optimal for
selective capture of macrophages while minimizing the overall
size of arrays. Recently, we have shown the use of “clickable”
antifouling polymer brushes as substrate for polymer pen lithog-
raphy (PPL)[55] to generate click chemistry based arrays to capture
proteins.[56] However, microchannel cantilever spotting (μCS),
where femtoliter-scale microdroplets of ink are transferred to
a substrate by a cantilever carrying a microfluidic channel,[57]
offer an ideal feature size for our purposes, closely resembling
the targeted cell size[58] and offers high accuracy in the genera-
tion of microarrays.[59] Therefore, μCS was chosen as litho-
graphic tool in our approach for providing the desired
localized highly specific binding places for adhesion of macro-
phages of different polarization, while preventing unspecific
binding of the macrophages and other macromolecules to the
substrate.
2. Results and Discussion
For the goal of achieving selective macrophage capture, two key
factors have to be considered: 1) specific receptors and 2) nonfoul-
ing material. To combine both of these in one approach, hierar-
chical polymer brushes were utilized.
2.1. Preparation of Polymer Brushes
Hierarchical polymer brushes were synthesized from silicon and
glass substrates. The brushes consist of a bottom block
(poly(oligoethylene glycol methylether methacrylate)) with repel-
lent properties and a top block which can be functionalized by
click chemistry (refer to Figure 1). The synthesis of the polymer
brushes can be divided into three steps: 1) formation of SAM of
initiator, 2) grafting of the antifouling block, and 3) grafting of
the azide-functional block. The initiator, 11–(trichlorosilyl)
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undecyl 2-bromo-2-methylpropanoate, was selected because of its
ability to form well-organized and stable monolayers on different
substrates.[60] The polymer brushes were grafted from the initia-
tor layer using surface-initiated atom transfer radical polymeri-
zation (SI-ATRP). This type of polymerization provides living
end groups which are crucial for successful grafting of the top
block. The grafting of each block was monitored by ellipsometry
using Si wafer as a model substrate. The dry ellipsometric thick-
ness of the first block was 20 nm, further increasing to 24 nm
after grafting of the second block, and remained the same after
functionalization of brushes with azide groups (Table S1,
Supporting Information).
2.2. Quantification of Macrophage Repellency
The repellence to unspecific macrophage adhesion was first
tested via a dot plot of nonpolarized (MΦ), M1, and M2 macro-
phages. To assess the selectivity, an assay was developed in
which some areas of the surfaces are capable of capturing
antibody-labeled macrophages while the other remain repellent.
The macrophages were incubated with subtype-specific biotiny-
lated antibodies and nonspecific biotinylated IgG for isotype
control, prior to the test. This yields the macrophages’ surfaces
decorated with biotin. To test repellence versus binding, macro-
scopic spots bearing streptavidin were created, capable of captur-
ing biotin-decorated macrophages, whereas the remaining
surface should be nonadhesive. To generate the streptavidin spot,
a drop of a biotin-dibenzocyclooctyne (biotin-DBCO) solution
was deposited using a pipette on the surface of polymer brushes
with azide groups. SPAAC provided fast and efficient immobili-
zation of biotin. Subsequently, the substrates were incubated
with a streptavidin solution, resulting in millimeter-scale strep-
tavidin bearing dots on the surfaces while the rest of them remain
with unfunctionalized polymer brushes. Such design allows cap-
turing biotin-bearing cells on the streptavidin-exhibiting area over
a biotin–streptavidin–biotin sandwich structure. To test this, the
prepared surfaces were incubated with macrophages of different
polarizations obtained from cell culture (all macrophages were
either incubated with antibodies specific to their respective subtype
or (for the control experiments) with an unspecific IgG control anti-
body). Almost no macrophages adhered on the nonfunctionalized
brushes (Figure 2a). On the other hand, streptavidin-bearing poly-
mer brushes after incubation with the macrophages labeled with
biotinylated specific antibody showed highly specific binding to the
surface (Figure 2b). These demonstrate that polymer brushes are
able to prevent unspecific adhesion of highly adherent macro-
phages while functionalization of brushes with streptavidin leads
to increased binding efficiency. Finally, on incubation of the dot-
plotted surface with the respectivemacrophages pre-incubated with
control antibody, only minor unspecific binding for MΦ and M1
and strongly reduced binding of M2 macrophages is observed
(Figure 2c). The remaining adhesion of M2 macrophages incu-
bated with IgG can be explained by a slight binding of the IgG
control to the macrophages. All cell subtypes exhibit statistically
significant binding to the specific antibodies compared with the
control areas (MΦ: P< 0.001, M1: P< 0.01, M2: P< 0.05, raw data
given in Table S2, Supporting Information). The difference in con-
fidence level could be caused by differences in affinity of the control
antibody to the specific antigens at the cell membrane of the spe-
cific macrophage. Table 1 shows the efficacy of the brushes in
reducing the unspecific adhesion of macrophages. Remarkably,
only few macrophages ((5 3) to (6 4) cells on 0.762 mm2
Figure 1. Preparation of microarrays on hierarchical polymer brushes for the selective capture of macrophages. a) Synthesis of polymer brush.
b) Microarray generation by μCS of biotin–DBCO. c) After incubation with streptavidin, cells specifically labeled with biotinylated antibodies are selectively
captured on the biotin–streptavidin arrays.
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screened, thus only (7 5) cells·mm2 in average) adhered
unspecifically, compared with specifically captured cells
[(174 58) to (421 95) cells on 0.762 mm2 screened, thus
(228 76) cells·mm2 to (552 100) cells·mm2]. These results
are especially striking when compared with other standard surfaces
and blocking methods, which are not sufficient for efficient mac-
rophage repellence. As controls, commonly used surfaces and dif-
ferent blocking agents were tested: 1) fetal bovine serum (FBS), as a
common blocking strategy in biology, 2) SEA BLOCK blocking as
used in immunohistochemistry based on adsorption of macromo-
lecules from steelhead salmon fish serum, 3) SEA BLOCKþ 1%
TWEEN, as well as 4) tissue culture plates (as positive
control/comparison). As shown in Figure S1, Supporting
Information, all these blocking strategies failed to prevent adsorp-
tion of macrophages.
2.3. Specific Macrophage Adhesion
The localized specific capture of macrophages was explored by
generating microarrays with binding sites supporting a biotin–
streptavidin sandwich structure. A microspotting approach
was used to locally functionalize the polymer brush with biotin–
DBCO. This allows subsequent streptavidin binding that acts as
capture site for biotinylated-antibody bearing macrophages.
Typically, arrays of 20 20 dot features were spotted via μCS,
which deposits small femtoliter-sized droplets on a surface.[57]
These droplets can act as reaction vessels where click-reactions
take place.[58,61,62] After 20min of binding, the excess ink was
washed away and samples were incubated with fluorescently
labeled streptavidin to activate the array for macrophage capture.
A typical result of the arraying procedure is shown in Figure 3.
The arrays used in our studies consist of spots with a radius of
(7.0 0.6) μm (derived from the measured area per spot of
[154.5 25.1] μm2 and assuming a circular shape) and a cen-
ter-to-center distance (pitch) of 50 μm spanning over a square
millimeter.
Figure 2. Fluorescence image of a dot plot surface after incubation with biotinylated MΦ, M1, and M2macrophages. a) Bare antifouling polymer brushes
after incubation with macrophages (unspecific binding), b) binding of macrophages incubated with a biotinylated specific antibody to biotin–streptavidin
functionalized brushes (specific binding), c) binding of macrophages incubated with biotinylated control IgG to biotin–streptavidin functionalized
brushes (control). Cells were stained with DAPI. Scale bars equal 100 μm in each image.
Table 1. Comparison in cell count of specific and unspecific binding
potential of surfaces functionalized by polymer brushes. Numbers
represent number of cells per 0.762mm2 area. For each value, at least
four different areas on a dot plot were averaged and the standard
deviation was calculated. Results are statistically significant (t-test,
P< 0.05).
Unspecific binding Specific antibody IgG control
MΦ 6 4 228 78 66 42
M1 5 3 174 58 56 14
M2 6 4 421 95 247 75
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In our studies, we focused on the feasibility of specific capture
of polarized macrophages as they are the most important target
for medical application. M1 macrophages comprise inflamma-
tory and antitumoral effects, whereas the anti-inflammatory M2
macrophages support tumor growth.[63] The macrophages were
either incubated with respective specific biotinylated antibody or
with an (also biotinylated) nonspecific IgG control antibody and
then incubated on the capture arrays. After washing and staining,
the capture arrays and adhering cells were imaged by fluores-
cence microscopy (Figure 4). A high correlation of captured mac-
rophages with the array features is observed on visual inspection
(Figure 4a,b). Fewer cells were observed on the capture array of
macrophages incubated with the nonspecific IgG control, com-
pared with incubation with specific antibodies. To quantify the
cell capture, cells on a capture spot were counted in comparison
to cells attached to the unmodified surface. This results in a cell
count of 217 cells on feature versus 56 unspecifically bound for
M1 macrophages, and 203 cells on feature versus 32 unspecifi-
cally bound cells for M2 macrophages. For the IgG control sam-
ples (Figure 4c), a total cell count of 82 (55 cells on feature vs 27
in between features) for M1 macrophages, and 23 cells (12 on
feature vs 11 in between features) for M2 macrophages was
observed. These results show the high specificity of macrophage
capture, as shown in the ratio of on feature (specific capture) to
total cell count being 79.5% for M1 and 86.4% for M2 macro-
phages pre-incubated with specific antibodies. Furthermore,
the total cell count is 3.3 times higher for M1 and 10.2 times
for M2 macrophages, respectively, using specific antibody versus
the IgG controls (raw cell counts given in Table S3, Supporting
Figure 3. a) Streptavidin microarrays for cell capture. Biotin was printed by
μCS on the polymer brushes. Streptavidin-Cy3 was then incubated on the
substrate. Scale bar is 100 μm in both images. b) Histogram of feature size
in the macrophage capture array. Average feature area (calculated from
370 features in eight different images) is (154.5 25.1) μm2. Assuming
a circular shape of the features, this area corresponds to a radius of
(7.0 0.6)μm.
Figure 4. Selective capture of polarized M1 andM2 macrophages on microarrays. The cells were incubated with biotinylated antibodies in form of specific
and nonspecific IgG (as isotype control) prior to the test. a) Localized capture of macrophages incubated with biotinylated specific antibodies on micro-
arrays. b) Zoom-in of the areas (white frames) in (a) of the corresponding macrophage subtype. c) Binding of macrophages on microarrays incubated with
nonspecific biotinylated IgG (isotype control). Cells were stained with DAPI and CTOG, arrays with Cy-3. Scale bars are 100 μm in all pictures.
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Information). Moreover, the capture approach works also when
cells are not incubated with biotinylated antibody beforehand but
the antibody is put on the substrate’s capture features instead
(Figure S3, Supporting Information)—which can be exploited
for multiplexed (i.e., more than one macrophage subtype) selec-
tive cell adhesion within one array. The intrinsic distinction
between specifically bound (co-located with array feature) and
unspecifically bound (in between features) can additionally be
used in cell-picking applications to ensure low false-positive
counts, as unspecifically bound macrophages can be easily
excluded.
3. Conclusion
Our studies demonstrated that the hierarchical antifouling poly-
mer brushes could repel the adhesion of macrophages, one of the
most adherent cell types.[25,26] Furthermore, the polymer brushes
were functionalized to introduce specific capture arrays based on
biotin–DBCO immobilization with subsequent macrophage cap-
ture over a biotin–streptavidin–biotin sandwich. The resulting
arrays show good specificity for macrophage capture based on
specific antibody interaction and offer additional control for false
positives (in the form of unspecifically adhering cells) by check-
ing co-location of array features with adhering macrophages.
Such arrays could be upscaled for high-throughput production
by additional printing methods as μCS with parallel tips[64] or
PPL[56,65] with adjusted custom stamps of appropriate feature
size, and be incorporated into microfluidics for future applica-
tion in biomedical experiments and clinical diagnostics.[65–67]
Overall, the approach opens up the route for easy and efficient
macrophage capture and future sorting applications in research
and medical practice.
4. Experimental Section
Materials: Oligo(ethylene glycol) methyl ether methacrylate
(MeOEGMA, Mn¼ 300 g mol1), glycidyl methacrylate (≥97.0%,
GMA), CuBr2 (99.999% trace metals basis), CuBr (99.999% trace metals
basis), 2,2’-bipyridyl (≥99% BiPy), sodium azide (≥99%, ultra dry, NaN3)
were purchased from Sigma-Aldrich, Germany. Toluene (99.85%),
N,N-dimethylformamide (99.8%, DMF) and dichloromethane (99.9%,
CH2Cl2) extra dry over molecular sieve were purchased from Acros
Organic, Germany. Methanol (MeOH), ethanol (EtOH), acetone, and tol-
uene were purchased from VWR Chemicals, Germany. Aluminum oxide 90
basic was purchased from Carl Roth, Germany. Milli-Q water was obtained
using Elga USA filter Purelab Plus UF purification system (PL5113 02), UK
11-(trichlorosilyl)undecyl 2-bromo-2-methylpropanoate, was synthesized
according to the modified method from literature.[68,69]
Substrate Activation and Immobilization of Initiator: Round glass
substrates (15mm diameter) were rinsed twice with EtOH and Milli-Q
water, dried with N2, and activated inside a vacuum plasma cleaning
machine (TePla PS100, Germany). The duration of treatment was
20min with oxygen flow of 40mL min1 and micro wave power of
200W. Immediately after, the substrates were immersed in a freshly pre-
pared solution of 11-(trichlorosilyl)undecyl 2–bromo-2–methylpropanoate
in dry toluene (1mg mL1). The silanization was allowed to proceed for
3 h in a dry environment to form SAM of initiator. The substrate were
rinsed with toluene, acetone, EtOH, and Milli-Q water and dried with N2.
Grafting of Polymer Brushes: The hierarchically structured polymer
brushes consisting of two blocks were synthesized using a protocol
reported previously.[51] A brief description of the procedure is: 1) For
the preparation of an antifouling block, 15mL of MeOH and a monomer
solution [MeOEGMA (14.2 g, 47.4 mmol) in 12.5mL of Milli-Q water] were
placed in two separate round-bottom flasks and degassed by bubbling N2
for 1 h. After degassing, 12.5mL of MeOH was transferred to previously
degassed flask containing catalyst (BiPy (386.8mg, 2.5 mmol), CuBr2
(41.9mg, 188 μmol), and CuBr (134.6 mg, 938 μmol)) under N2 atmo-
sphere and stirred until complete dissolution. Subsequently, the monomer
and the catalyst solutions were mixed by transferring the solution using a
gas-tight syringe under N2 protection. The obtained polymerization mix-
ture was transferred under N2 atmosphere to previously degassed reactor
containing substrates with SAM of initiator. The polymerization was car-
ried out at 30 C for 20min and stopped by adding Milli-Q water. The sub-
strates were rinsed twice with EtOH and Milli-Q water and dried with N2.
2) For the preparation of an azide-functional block, GMA was passed
through the basic alumina column to remove inhibitor. Then, obtained
GMA (16.7 g, 117.6mmol), BiPy (458mg, 2.9mmol) CuBr2 (52.5 mg,
235 μmol), and dry DMF (24mL) were placed in a round-bottom flask
and degassed for 1 h by bubbling N2. Subsequently, CuBr (168.4 mg,
1.2 mmol) was added to the flask under N2 protection and stirred until
complete dissolution. The obtained polymerization mixture was trans-
ferred to previously degassed reactor containing substrates with
MeOEGMA block, used as macroinitiator. The polymerization was allowed
to proceed at 30 C for 4 h and was stopped by removing samples from the
reactor. The substrates were rinsed twice with dry DMF and dry CH2Cl2
and dried with N2. Afterward, the slides with obtained diblock polymer
brushes were immersed in 40mL solution of NaN3 (3.4 mg mL
1) in
dry DMF to functionalize the GMA block with azide groups. The reaction
was carried out at 60 C for 24 h. The samples were washed with DMF,
EtOH, and Milli-Q water and dried with N2.
Preparation of Dot Plot Substrates: Ink was prepared by mixing biotin-
PEG4-DBCO (2mgmL1 in DMSO) (Jena Bioscience, Germany) with 87%
glycerol (7:3) (Sigma Aldrich, Germany). Substrates were activated for cell
capture by pipetting 0.5 μL ink onto substrates. The reaction was carried
out on a hotplate for 20 min at 37 C. Substrates were then washed three
times with phosphate buffer saline (PBS). Obtained samples were incu-
bated with 100 μL of 1 mg mL1 streptavidin-Cy3 (Sigma-Aldrich,
Germany) in PBS (1:100) right before cell capture experiments for 1 h
at room temperature and washed two times with PBS.
Printing of Capture Arrays: Spotting of the binding sites was imple-
mented with surface patterning tool (SPT) probes[70] (SPT-S-C10S,
Bioforce Nanosciences, USA) on a NLP 2000 system (NanoInk, USA) with
a self-made custom tip holder. The SPTs were rendered hydrophilic by
oxygen plasma treatment at 0.2 mbar, 100% O2, 200W, for 2 min in an
Atto plasma cleaner (Diener Electronic, Germany) immediately before use.
Ink for μCS was prepared as described in the previous section. Arrays had
dimensions of 20 20 dots with a pitch of 50 μm in each direction. Typical
conditions for spotting were a dwell time of 0.1 s and a relative humidity of
20%. After printing substrates were incubated for 20 min at 37 C, washed
and incubated with streptavidin-Cy3 as described in the previous section.
Macrophage Isolation and Cultivation: Human monocytes were isolated
from buffy coats from peripheral blood of healthy volunteers obtained
from the Red Cross by Ficoll gradient centrifugation. Cells were purified
via the monocyte specific surface marker cluster of differentiation 14
(CD14). This was done using Magnetic Activated Cell Sorting (MACS,
Miltenyi Biotec GmbH, Bergisch Gladbach, Germany). The purity of
CD14 positive cells was at least 95% determined by flow cytometry in
an Agilent 2100 Bioanalyzer (Agilent Technologies, Germany).
The obtained cells were cultured in McCoy’s 5 A medium supple-
mented with 15% FBS, 1% L-glutamine, and 2% nonessential amino acids
(all obtained from Biochrom, Germany). The tests were performed after
the polarization to M1 or M2 macrophages or with unpolarized macro-
phages (MΦ).
Macrophage Polarization: After isolation and cultivation, cells were
differentiated as described earlier.[2,71] Briefly, for M1 polarization, cells
were incubated for 6 days with 50 ng mL1 granulocyte–macrophage col-
ony-stimulating factor (GM-CSF) from E. coli (Invitrogen/Thermo Fisher
Scientific, Germany) in culture medium. Then cells were cultured for
24 h with 50 ng mL1 lipopolysaccharide (LPS) (clone: E. coli O55:B5,
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Sigma-Aldrich, Germany) and 20 ng mL1 interferon gamma (IFNγ) from
E. coli (Invitrogen/Thermo Fisher Scientific, Germany). For M2 polariza-
tion, cells were incubated for 6 days at 37 C and 5% CO2 with
50 ngmL1 macrophage colony-stimulating factor (M-CSF) frommamma-
lian (Invitrogen/Thermo Fisher Scientific, Germany) in culture medium.
Subsequently, cells were cultivated for 24 h with 20 ng mL1
interleukin-4 (IL-4) and 20 ng mL1 interleukin–13 (IL–13) both from
E. coli (Invitrogen/Thermofischer, Germany), also in culture medium.
To obtain undifferentiated macrophages, the monocytes were cultured
for 6 days with 50 ng mL1 of M–CSF in the culture medium.
Cell Adhesion Experiments: To investigate the reaction of cells to
different surface structures, the macrophages were removed from the cell
culture plate and grown on the respective surface for 12 h in PBS without
any cytokines added. For microscopic analysis, cells were fixed by incuba-
tion with 4% paraformaldehyde solution for 10min.
Preparation of Biotin-Labeled Macrophages: During the relevant
experimental setups, cells were pre-incubated with cell-specific biotiny-
lated antibodies prior to the attachment to the streptavidin-activated
repellent surfaces.
Three types of biotinylated antibodies were used: For nonpolarized
macrophages, biotinylated anti-CD14 (clone: 61D3, Invitrogen/Thermo
Fisher Scientific, Germany) was used. For the M1 subtype, biotinylated
anti-CD80 (clone: 2D10.4, Invitrogen/Thermo Fisher Scientific,
Germany) was chosen. For capturing cells with a M2 subtype, biotinylated
anti-CD163 (clone: eBioGHI/51, Invitrogen/Thermo Fisher Scientific,
Germany) was applied. Controls were performed using biotinylated IgG1
kappa isotype control antibody (clone: P3.6.2.8.1, Invitrogen/Thermo
Fisher Scientific, Germany). Per substrate of 15mm diameter, 106 cells
were incubated with 1 μg of antibody in 100 μL BSA/PBS 0.1% w/V for
1 h at 37 C on a shaker. Then, cells were centrifuged for 7 min at
1000 rpm and resuspended in 100 μL warm PBS and given on the
functionalized substrate.
Direct Incubation of Cells: Substrates were prepared as described earlier.
They were then incubated with biotinylated antibodies corresponding to
the target cell type (see earlier section). 1 μg of antibody in 100 μL PBS
was incubated on the substrates for 1 h at room temperature. Then, cells
were washed two times with PBS. 106 cells per substrate were then cen-
trifuged and resuspended in 100 μL warm PBS. Incubation of cells on the
surface started directly after antibodies were attached.
Spectroscopic Ellipsometry: Si wafers were used as a model substrate to
determine thickness of the polymer brushes. The dry ellipsometric thick-
ness was measured using an OMT Ellipsometer and was analyzed using
VisuEl software version 3.4.1, Optische Messtechnik GmbH. Ellipsometric
data were measured in air at room temperature in the wavelength range
λ¼ 460–870 nm at the angle of incidence of 70.
Optical Microscopy: For microscopy, cells were stained with 4 0,6-diami-
dino-2-phenylindole (DAPI) (1:1000) and Cell Trace Oregon Green
(CTOG) (2.5 μg mL1) (Invitrogen/Thermo Fisher Scientific, Germany)
after fixation. Samples were analyzed using a fluorescence microscope
Nikon Eclipse TE2000-U (Nikon, Japan) and a Leica TCS SP8 confocal laser
scanning microscope (Leica, Germany) using a hybrid-detector. All pic-
tures were taken with a 10 objective. Depending on the experimental
setup, DAPI, Fluorescein (FITC), and Cy3 channels were used.
Evaluation of Array Feature Size: The feature size in the printed arrays
was obtained by analyzing eight different images bearing 370 features
using the software ImageJ.[72,73] The images were first thresholded and
features detected by the “find particle” function, then feature areas were
extracted. Based on the feature area, feature radii were calculated (assum-






where A is the area of the features and r is the corresponding radius. The
error ranges reported in area and radius correspond to one standard
deviation.
Cell Counting for Dot Plots and Capture Arrays: Cell counting in the dot
plot experiments was done by counting the number of adherent cells in
images corresponding to an area of 0.762mm2 of the unfunctionalized
polymer brush surface (unspecific binding), on the dot plots functional-
ized with cell-specific antibodies and the dot plots functionalized with
the IgG control antibody. For each case, at least four different areas were
analyzed, averaged, and the standard deviation calculated. To check for
statistical significance, a Student’s t-test was performed on the data.
For evaluation of the specific binding on the capture arrays, images
from three samples each for M1/M2 capture containing about 1200 array
features were counted for cells sitting “on feature” (i.e., the cell counted is
co-located with an array feature) versus cells sitting “off feature” (i.e., in
between features in the area of the array). The same procedure was
repeated for images from two samples each for the M1/M2 IgG control
samples.
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